Data / Crowdfunding / California / BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc.: crowdfunding raise on NetCapital Funding Portal Inc., $10,001 to $1,069,997 (2022)
BioEclipse Therapeutics, Inc., a corporation in Mountain View, CA, filed a Form C with the SEC on April 1, 2022 to raise $10,001 to $1,069,997 in common stock through NetCapital Funding Portal Inc.. The offering closed on April 19, 2022. In its most recent fiscal year it reported $0 in revenue and a net loss of $4,391,188, with 5 employees.
SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.
- Website
- www.bioeclipse.com
- Funding portal
- NetCapital Funding Portal Inc.
- Address
- 319 North Bernardo Avenue, Mountain View, CA 94043
- Legal form
- Corporation
- Jurisdiction
- DE
- Incorporated
- May 26, 2006
- SEC CIK
- 0001780708
Offering terms
From the amendment filed April 1, 2022.
- Security
- Common Stock
- Price
- $2.55
- Target
- $10,001
- Maximum
- $1,069,997
- Deadline
- April 19, 2022
- Portal compensation
- Up to 4.9% of amount raised for a successful offering and a listing fee of up to $5,000
Financials
From the Form C/A filed April 1, 2022.
| Most recent fiscal year | Prior fiscal year | Source | |
|---|---|---|---|
| Revenue | $0 | $0 | sec.gov |
| Cost of goods sold | $0 | $0 | sec.gov |
| Net income | $-4,391,188 | $-2,415,736 | sec.gov |
| Taxes paid | $0 | $0 | sec.gov |
| Total assets | $2,956,073 | $5,839,337 | sec.gov |
| Cash | $2,331,499 | $5,394,836 | sec.gov |
| Accounts receivable | $0 | $0 | sec.gov |
| Short-term debt | $75,862 | $0 | sec.gov |
| Long-term debt | $0 | $0 | sec.gov |
Filings
| Filed | Filing | Target | Maximum | Deadline | Note | Source |
|---|---|---|---|---|---|---|
| April 1, 2022 | Amendment | $10,001 | $1,069,997 | April 19, 2022 | the issuer is extending the offering deadline. | sec.gov |
| February 28, 2022 | Amendment | $10,001 | $1,069,997 | April 1, 2022 | the issuer is extending the offering deadline. | sec.gov |
| January 19, 2022 | Offering | $10,001 | $1,069,997 | March 1, 2022 | sec.gov |
Updated April 1, 2022. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.